Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Sales (2021 - 2024)

Solid Biosciences' Return on Sales history spans 4 years, with the latest figure at 507.28% for Q4 2024.

  • For Q4 2024, Return on Sales rose 8870.0% year-over-year to 507.28%; the TTM value through Dec 2024 reached 354.7%, down 6387.0%, while the annual FY2024 figure was 354.7%, N/A changed from the prior year.
  • Return on Sales for Q4 2024 was 507.28% at Solid Biosciences, up from 401.66% in the prior quarter.
  • Across five years, Return on Sales topped out at 507.28% in Q4 2024 and bottomed at 13.15% in Q1 2022.
  • The 4-year median for Return on Sales is 8.62% (2023), against an average of 144.55%.
  • The largest annual shift saw Return on Sales crashed -808bps in 2022 before it skyrocketed 41450bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 6.91% in 2021, then skyrocketed by 159bps to 4.08% in 2022, then soared by 10157bps to 418.58% in 2023, then rose by 21bps to 507.28% in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Return on Sales are 507.28% (Q4 2024), 401.66% (Q3 2024), and 287.62% (Q2 2024).